Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 172 | N/A | N/A |
| Receivables | 387 | N/A | N/A |
| Other current assets | 151 | 0 | 0 |
| TOTAL | $710 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 978 | N/A | N/A |
| Other Non-Current Assets | 432 | 0 | 0 |
| TOTAL | $1,410 | $N/A | $N/A |
| Total Assets | $2,120 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 165 | 0 | 0 |
| Accrued Expenses | 137 | N/A | N/A |
| TOTAL | $436 | $N/A | $N/A |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $436 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 12,000 | N/A | N/A |
| Retained earnings | -10,316 | N/A | N/A |
| TOTAL | $1,684 | $N/A | $N/A |
| Total Liabilities And Equity | $2,120 | $0 | $0 |